⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 9, 2026Neurology

A Longitudinal Observational Study for Assessing Clinical Markers in Spinocerebellar Ataxia Type 31 (P4-16.012)

Kinya Ishikawa Hanako Aoki

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to understand how spinocerebellar ataxia type 31 progresses by examining clinical markers over time.
Longitudinal observational study design assessing patients with spinocerebellar ataxia type 31
Focus on collecting clinical markers to evaluate disease progression
Establishment of key clinical markers for tracking progression in spinocerebellar ataxia type 31

Implication

Longitudinal observational study assesses clinical markers in spinocerebellar ataxia type 31, suggesting a deeper understanding of progression.

Abstract

To understand clinical progression of spinocerebellar ataxia type 31 (SCA31) through establishing clinical observational program.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ishikawa et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf34dfaef96ed7f055d59 https://doi.org/10.1212/wnl.0000000000217832

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Clinical Observational Study for Developing Disease Modifying Therapy Against Spinocerebellar Ataxia Type 31 (P7-3.020)2024
2Multimodal, Longitudinal Profiling of <scp>SCA1</scp> Identifies Predictors of Disease Severity and Progression2024 · 10 citations
3Sensitivity of Advanced Magnetic Resonance Imaging to Progression over Six Months in Early Spinocerebellar Ataxia2024 · 14 citations
4Longitudinal progression, metrics, age-dependence, and modifiers of ataxia severity in SCA27B: a multicentre study of 219 patientsRCT · 2026
5Value of <scp>MRI</scp> Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3Human Clinical Trial · 2026 · 6 citations